Currently unavailable.
Stroke is a devastating disease accounting for 5.5 million deaths annually worldwide. Despite significant preclinical and clinical investigations, with more than 1000 candidate neuroprotective stroke drugs investigated and nearly 200 clinical trials, no effective therapy other than tissue plasminogen activator (TPA) has been approved. The appropriate use of animal models and clinical trial design will undoubtedly improve the odds of identifying effective therapeutics. Oxygen Glucose Deprivation Model https://acroscell.creative-bio....array.com/oxygen-glu